Global Head, Business Development & Licensing Oncology
Novartis, East Hannover (US)
Syed Kazmi is VP, Global Head Oncology Business Development & Licensing, Syed leads all BD&L efforts for Novartis Oncology BD&L including Search & Evaluation, Transactions, Due Diligence and Alliance Management. Prior to Novartis, Syed worked as the Executive Director of Business Development at Amgen, responsible for corporate mergers and acquisitions, global licensing and strategic collaborations; he also served as the Head of International Business Development. Prior to joining Amgen in 2012, Syed served as Vice President and Head, Business Development & Strategic Planning, at Ligand Pharmaceuticals. Syed also worked for Johnson & Johnson as Principal Scientist in the R&D organization. Syed has a Ph.D. in Life Sciences (Biochemistry) and an executive MBA.